Replies to post #42382 on Ariad Pharmaceuticals Inc fka ARIA

[grandma_of_jbraika]

You will regret if you Don't Buy Ariad Pharmaceuticals Shares At These Levels.

The seeking Alpha article would be creditable if it did not mention "billionaire Stephen Cohen's hedge fund SAC Capital that sold 6.82 mill shares."

SAC Capital was forced to sell because the government’s noose was tightening around the neck of billionaire Steve Cohen’s SAC Capital hedge fund.

One seeking Alpha article tells you "Don't Buy Ariad Pharmaceuticals Shares At These Levels". However the other seeking Alpha article is positive on Ariad:

On the day that the company first announced a hold on the product, the stock was trading in the $18 range. As of December 20, the stock traded in the $6 range. Although not without risk, we believe the company is currently undervalued and could trend higher as people begin to again speculate on the company's future.

We believe the company's next earnings call will serve as a catalyst date. The company will be able to discuss how successful the resumption of Iclusig sales was and give additional guidance about future sales and trials.

We expect Ariad to rally over the coming months into the large gap created by the October 9 news.

These Small-Cap BioPharma Companies Have Catalysts Upcoming